Icagen’s biology team accelerates the discovery and advancement of therapeutic programs through world-class expertise in a wide range of therapeutic areas, with specific expertise in neuroscience and rare diseases.

Our staff comprises interdisciplinary teams of highly-experienced, flexible and responsive pharmaceutical industry professionals who work in close collaboration with our partners to deliver value through the seamless integration of programs across the drug discovery chain, while ensuring successful and timely implementation of discovery programs.

Ranging from target identification to lead generation and beyond, Icagen’s Discovery Biology team offers a wide range of stand-alone services, as well as fully integrated, cost-effective drug discovery programs through collaborative partnerships.

Our specific capability areas are:

  • Assay development
    • Cell line generation & FACS cloning
    • Human stem cell models and derived tissues
  • High-Throughput Screening (HTS) and Ultra-High-Throughput Screening (uHTS)
  • Cellular, biochemical, and radioactive high content screening
    • Phenotypic screens
  • Early ADME